161 related articles for article (PubMed ID: 32020804)
1. Sequential Intra-Intercellular Delivery of Nanomedicine for Deep Drug-Resistant Solid Tumor Penetration.
He Y; Cong C; Li L; Luo L; He Y; Hao Z; Gao D
ACS Appl Mater Interfaces; 2020 Feb; 12(8):8978-8988. PubMed ID: 32020804
[TBL] [Abstract][Full Text] [Related]
2. Computer-assisted engineering of programmed drug releasing multilayer nanomedicine via indomethacin-mediated ternary complex for therapy against a multidrug resistant tumor.
Che L; Liu Z; Wang D; Xu C; Zhang C; Meng J; Zheng J; Yuan H; Zhao G; Zhou X
Acta Biomater; 2019 Oct; 97():461-473. PubMed ID: 31344512
[TBL] [Abstract][Full Text] [Related]
3. Targeting tumor hypoxia with stimulus-responsive nanocarriers in overcoming drug resistance and monitoring anticancer efficacy.
Xie Z; Guo W; Guo N; Huangfu M; Liu H; Lin M; Xu W; Chen J; Wang T; Wei Q; Han M; Gao J
Acta Biomater; 2018 Apr; 71():351-362. PubMed ID: 29545193
[TBL] [Abstract][Full Text] [Related]
4. Doxorubicin and adjudin co-loaded pH-sensitive nanoparticles for the treatment of drug-resistant cancer.
Wang Q; Zou C; Wang L; Gao X; Wu J; Tan S; Wu G
Acta Biomater; 2019 Aug; 94():469-481. PubMed ID: 31141733
[TBL] [Abstract][Full Text] [Related]
5. Thermo-sensitive polypeptide hydrogel for locally sequential delivery of two-pronged antitumor drugs.
Wei L; Chen J; Zhao S; Ding J; Chen X
Acta Biomater; 2017 Aug; 58():44-53. PubMed ID: 28576715
[TBL] [Abstract][Full Text] [Related]
6. Tumor-Acidity-Cleavable Maleic Acid Amide (TACMAA): A Powerful Tool for Designing Smart Nanoparticles To Overcome Delivery Barriers in Cancer Nanomedicine.
Du JZ; Li HJ; Wang J
Acc Chem Res; 2018 Nov; 51(11):2848-2856. PubMed ID: 30346728
[TBL] [Abstract][Full Text] [Related]
7. Enhancing tumor chemotherapy and overcoming drug resistance through autophagy-mediated intracellular dissolution of zinc oxide nanoparticles.
Hu Y; Zhang HR; Dong L; Xu MR; Zhang L; Ding WP; Zhang JQ; Lin J; Zhang YJ; Qiu BS; Wei PF; Wen LP
Nanoscale; 2019 Jun; 11(24):11789-11807. PubMed ID: 31184642
[TBL] [Abstract][Full Text] [Related]
8. Rational Design of Nanoparticles to Overcome Poor Tumor Penetration and Hypoxia-Induced Chemotherapy Resistance: Combination of Optimizing Size and Self-Inducing High Level of Reactive Oxygen Species.
Deng L; Feng Z; Deng H; Jiang Y; Song K; Shi Y; Liu S; Zhang J; Bai S; Qin Z; Dong A
ACS Appl Mater Interfaces; 2019 Sep; 11(35):31743-31754. PubMed ID: 31389686
[TBL] [Abstract][Full Text] [Related]
9. Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts.
Zhong Y; Zhang J; Cheng R; Deng C; Meng F; Xie F; Zhong Z
J Control Release; 2015 May; 205():144-54. PubMed ID: 25596560
[TBL] [Abstract][Full Text] [Related]
10. Co-delivery of cisplatin and doxorubicin by covalently conjugating with polyamidoamine dendrimer for enhanced synergistic cancer therapy.
Guo XL; Kang XX; Wang YQ; Zhang XJ; Li CJ; Liu Y; Du LB
Acta Biomater; 2019 Jan; 84():367-377. PubMed ID: 30528609
[TBL] [Abstract][Full Text] [Related]
11. Sequentially Responsive Shell-Stacked Nanoparticles for Deep Penetration into Solid Tumors.
Chen J; Ding J; Wang Y; Cheng J; Ji S; Zhuang X; Chen X
Adv Mater; 2017 Aug; 29(32):. PubMed ID: 28632302
[TBL] [Abstract][Full Text] [Related]
12. Smart doxorubicin nanoparticles with high drug payload for enhanced chemotherapy against drug resistance and cancer diagnosis.
Yu C; Zhou M; Zhang X; Wei W; Chen X; Zhang X
Nanoscale; 2015 Mar; 7(13):5683-90. PubMed ID: 25740312
[TBL] [Abstract][Full Text] [Related]
13. Use of Oppositely Polarized External Magnets To Improve the Accumulation and Penetration of Magnetic Nanocarriers into Solid Tumors.
Liu JF; Lan Z; Ferrari C; Stein JM; Higbee-Dempsey E; Yan L; Amirshaghaghi A; Cheng Z; Issadore D; Tsourkas A
ACS Nano; 2020 Jan; 14(1):142-152. PubMed ID: 31854966
[TBL] [Abstract][Full Text] [Related]
14. Zinc Oxide Nanoparticles as Adjuvant To Facilitate Doxorubicin Intracellular Accumulation and Visualize pH-Responsive Release for Overcoming Drug Resistance.
Liu J; Ma X; Jin S; Xue X; Zhang C; Wei T; Guo W; Liang XJ
Mol Pharm; 2016 May; 13(5):1723-30. PubMed ID: 27070828
[TBL] [Abstract][Full Text] [Related]
15. Integration of cascade delivery and tumor hypoxia modulating capacities in core-releasable satellite nanovehicles to enhance tumor chemotherapy.
Wang J; Wang X; Lu SY; Hu J; Zhang W; Xu L; Gu D; Yang W; Tang W; Liu F; Cao Y; Liu H
Biomaterials; 2019 Dec; 223():119465. PubMed ID: 31518842
[TBL] [Abstract][Full Text] [Related]
16. Role of integrated cancer nanomedicine in overcoming drug resistance.
Iyer AK; Singh A; Ganta S; Amiji MM
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
[TBL] [Abstract][Full Text] [Related]
17. Hybrid Mesoporous-Microporous Nanocarriers for Overcoming Multidrug Resistance by Sequential Drug Delivery.
Wang L; Guan H; Wang Z; Xing Y; Zhang J; Cai K
Mol Pharm; 2018 Jul; 15(7):2503-2512. PubMed ID: 29768014
[TBL] [Abstract][Full Text] [Related]
18. Optical imaging and anticancer chemotherapy through carbon dot created hollow mesoporous silica nanoparticles.
Kang MS; Singh RK; Kim TH; Kim JH; Patel KD; Kim HW
Acta Biomater; 2017 Jun; 55():466-480. PubMed ID: 28373086
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of a novel biocompatible magnetic nanomedicine based on beta-cyclodextrin, loaded doxorubicin-curcumin for overcoming chemoresistance in breast cancer.
Rastegar R; Akbari Javar H; Khoobi M; Dehghan Kelishadi P; Hossein Yousefi G; Doosti M; Hossien Ghahremani M; Shariftabrizi A; Imanparast F; Gholibeglu E; Gholami M
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):207-216. PubMed ID: 29688063
[TBL] [Abstract][Full Text] [Related]
20. A Sequential Target-Responsive Nanocarrier with Enhanced Tumor Penetration and Neighboring Effect In Vivo.
Cui T; Yan Z; Qin H; Sun Y; Ren J; Qu X
Small; 2019 Oct; 15(42):e1903323. PubMed ID: 31468717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]